Virscio is a translational research and development company devoted to providing predictive preclinical research models and services to accelerate therapeutic candidate evaluation and reduce the risk of clinical failure. Virscio engages with leading pharmaceutical, biotechnology and academic sponsors and collaborators to design and execute a wide range of translational studies and research programs across multiple therapeutic areas. Our goal is to provide the most robust possible preclinical understanding of the efficacy and safety of novel therapies, medical devices and delivery technologies. Virscio is committed to achieving meaningful advances in human health through scientific innovation and efficiency, and humane and judicious application of preclinical test systems. Our team and work environment have been assembled and developed to achieve these goals, while maintaining utmost respect for animal welfare, our employees and the continued success of our clients and collaborators.